{
    "startDate": "2021-01-01",
    "endDate": "2021-12-31",
    "year": "2021",
    "quarter": "FY",
    "symbol": "TARA",
    "data": {
        "bs": [
            {
                "label": "Commitments and contingencies (Note 11)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 29517000
            },
            {
                "label": "Preferred stock, $0.001 par value, authorized 10,000,000 shares, Series 1 convertible preferred stock, 8,028 shares authorized at December 31, 2021 and 2020, respectively 8,027 shares issued and outstanding as of December 31, 2021 and 2020, respectively.",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 93112000
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 172596000
            },
            {
                "label": "Additional paid in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 256126000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 172596000
            },
            {
                "label": "",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2489000
            },
            {
                "label": "",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2489000
            },
            {
                "label": "Operating lease right-of-use asset",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 7171000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4298000
            },
            {
                "label": "Common stock, $0.001 par value, authorized 100,000,000 shares, Common stock, 11,235,731 and 11,211,840 shares issued and outstanding as of December 31, 2021 and 2020, respectively.",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "Marketable debt securities, non-current",
                "concept": "MarketableSecuritiesNoncurrent",
                "unit": "usd",
                "value": 39467000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 954000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10682000
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 161914000
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 161914000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -94012000
            },
            {
                "label": "Marketable debt securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 55505000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 35724000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 35724000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1719000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1719000
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -211000
            }
        ],
        "cf": [
            {
                "label": "Deferred offering costs recognized that were previously recorded in accrued expenses",
                "concept": "tara:DeferredOfferingCostsRecognizedPreviouslyRecordedInAccruedExpenses",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash (used in)/provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -228000
            },
            {
                "label": "Proceeds from the exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from - Series 1 Convertible Preferred Stock in Proteon Private Placement, net of offering costs",
                "concept": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Amortization of premium on marketable debt securities",
                "concept": "tara:AmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": 1737000
            },
            {
                "label": "Net cash (used in)/provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -98194000
            },
            {
                "label": "Proceeds from Preferred Offering, net of offering costs",
                "concept": "tara:ProceedsFromIssuancesOfConvertiblePreferredStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from maturity and redemption of marketable debt securities",
                "concept": "tara:ProceedsFromMaturityAndRedemptionOfMarketableDebtSecurities",
                "unit": "usd",
                "value": 27150000
            },
            {
                "label": "Operating lease right-of-use asset",
                "concept": "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "unit": "usd",
                "value": 1050000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 117000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 117000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -295000
            },
            {
                "label": "Stock based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 10362000
            },
            {
                "label": "Stock based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 10362000
            },
            {
                "label": "Stock based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 10362000
            },
            {
                "label": "Cash and restricted cash acquired in connection with the reverse merger with ArTara Therapeutics, Inc.",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchase of marketable debt securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 124748000
            },
            {
                "label": "Repayments under short-term debt",
                "concept": "RepaymentsOfShortTermDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from - Common Stock in Proteon Private Placement, net of offering costs",
                "concept": "tara:ProceedsFromSeptemberCommonStockNetOfOfferingCosts",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 40000
            },
            {
                "label": "Proceeds from Common Offering, net of offering costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Income Taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -47252000
            },
            {
                "label": "",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -47252000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -34502000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 418000
            },
            {
                "label": "Purchase of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 596000
            },
            {
                "label": "Purchase of insurance agreement with notes payable",
                "concept": "tara:PurchaseOfInsuranceAgreementWithNotesPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net (decrease)/increase in cash and cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": -132924000
            },
            {
                "label": "Common stock issued in connection with the reverse merger with ArTara Therapeutics, Inc.",
                "concept": "tara:CommonStockIssuedInConnectionWithTheReverseMerger",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from Underwriters Overallotment Option",
                "concept": "tara:ProceedsFromUnderwritersOverallotmentOption",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 576000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 26401000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 47489000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -47252000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -47252000
            },
            {
                "label": "Weighted average shares outstanding, basic and diluted (in Shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 11232576
            },
            {
                "label": "Weighted average shares outstanding, basic and diluted (in Shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 11232576
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 237000
            },
            {
                "label": "Net unrealized (loss) gain on marketable debt securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -211000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -47489000
            },
            {
                "label": "Other comprehensive income (loss)",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -211000
            },
            {
                "label": "Comprehensive Loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -47463000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 21088000
            },
            {
                "label": "Interest and investment income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 237000
            },
            {
                "label": "Interest expense",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": "N/A"
            }
        ]
    }
}